Back to Search
Start Over
Advances in the prevention of Alzheimer's disease and dementia
- Source :
- Journal of internal medicine, 275(3), 229-250. Wiley-Blackwell, Journal of Internal Medicine, 275, 229-50, Journal of Internal Medicine, 275, 3, pp. 229-50, Journal of internal medicine 275(3), 229-250 (2014). doi:10.1111/joim.12178
- Publication Year :
- 2014
- Publisher :
- Wiley, 2014.
-
Abstract
- Item does not contain fulltext BACKGROUND: Definitions and diagnostic criteria for all medical conditions are regularly subjected to reviews and revisions as knowledge advances. In the field of Alzheimer's disease (AD) research, it has taken almost three decades for diagnostic nomenclature to undergo major re-examination. The shift towards presymptomatic and pre-dementia stages of AD has brought prevention and treatment trials much closer to each other than before. METHODS: Here we discuss: (i) the impact of diagnostic reliability on the possibilities for developing preventive strategies for AD; (ii) the scientific evidence to support moving from observation to action; (iii) ongoing intervention studies; and (iv) the methodological issues and prospects for balancing strategies for high-risk individuals with those for broad population-based prevention. RESULTS: The associations between neuropathology and cognition are still not entirely clear. In addition, the risk factors for AD dementia and the neuropathological hallmarks of AD may not necessarily be the same. Cognitive impairment has a clearer clinical significance and should therefore remain the main focus of prevention. Risk/protective factors for dementia/AD need to be studied from a life-course perspective. New approaches in prevention trials include enrichment strategies based on genetic risk factors or beta-amyloid biomarkers (at least four ongoing pharmacological trials), and multidomain interventions simultaneously targeting various vascular and lifestyle-related risk factors (at least three ongoing trials). Experience from prevention programmes in other chronic diseases can provide additional methodological improvements. CONCLUSIONS: Building infrastructures for international collaborations is necessary for managing the worldwide public health problem of AD and dementia. The International Database on Aging and Dementia (IDAD) and the European Dementia Prevention Initiative (EDPI) are examples of ongoing international efforts aiming to improve the methodology of preventive studies and provide the basis for larger intervention trials.
- Subjects :
- Aging
medicine.medical_specialty
Population
Psychological intervention
Prodromal Symptoms
Disease
prevention & control [Alzheimer Disease]
Article
Cognition
Alzheimer Disease
Risk Factors
Internal Medicine
medicine
Humans
Dementia
ddc:610
Longitudinal Studies
education
Psychiatry
Preventive healthcare
methods [Preventive Medicine]
Clinical Trials as Topic
education.field_of_study
business.industry
Public health
diagnosis [Alzheimer Disease]
complications [Alzheimer Disease]
prevention & control [Dementia]
Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3]
medicine.disease
diagnosis [Dementia]
Clinical trial
Early Diagnosis
Preventive Medicine
etiology [Dementia]
Alzheimer's disease
analysis [Biomarkers]
business
Biomarkers
Subjects
Details
- ISSN :
- 09546820
- Volume :
- 275
- Database :
- OpenAIRE
- Journal :
- Journal of Internal Medicine
- Accession number :
- edsair.doi.dedup.....b133c020c14d2e2004a4636b7acf5c61